Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc > Nice big cup and handle formed ready to break out

<< Previous

Bullboard Posts

Next >>

Comment by akv1955on Feb 07, 2021 3:01pm

133 Views

Post# 32496427

RE:RE:RE:RE:RE:RE:RE:RE:Nice big cup and handle formed ready to break out

Congragulations, you've found out how many shares outstanding those companies have... some are incorrect but you still tried. Also, just because you've provided the number of shares outstanding, I'm not going to do your homework for you. Please respond back with at least 1000 words on what the shares outstanding for a company means to you and the ratios that go along with calculating the market cap and sp. Bonus points if you can explain how this all impacts MYCO.

I highly recommend reading a book or even education yourself before acting up. You've embarassed yourself.

Cheers

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity